Oncological outcomes of breast cancer patients after planned IORT boost with low-kV x-rays: results of the TARGIT BQR prospective phase IV trial
The TARGIT BQR (boost quality registry) phase IV trial investigates clinical outcomes of breast cancer patients with standard external-beam radiotherapy (EBRT) of the whole breast and intraoperative radiotherapy (IORT) with low-kV x‑rays as an anticipated tumor bed boost in a real-world setting.
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
19 May 2025
|
| In: |
Strahlentherapie und Onkologie
Year: 2025, Pages: 1-9 |
| ISSN: | 1439-099X |
| DOI: | 10.1007/s00066-025-02412-0 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00066-025-02412-0 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00066-025-02412-0 |
| Author Notes: | Lukas Goerdt, Janina Pömsl, Uta Kraus-Tiefenbacher, Viktoria Brück, Christina Kaiser, Ralf Keymer, Yasser Abo-Madyan, Katharina Fleckenstein, Sebastian Berlit, Benjamin Tuschy, Marc Sütterlin, Frederik Wenz, Elena Sperk |
| Summary: | The TARGIT BQR (boost quality registry) phase IV trial investigates clinical outcomes of breast cancer patients with standard external-beam radiotherapy (EBRT) of the whole breast and intraoperative radiotherapy (IORT) with low-kV x‑rays as an anticipated tumor bed boost in a real-world setting. |
|---|---|
| Item Description: | Gesehen am 01.09.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1439-099X |
| DOI: | 10.1007/s00066-025-02412-0 |